Cormorant Asset Management as of June 30, 2020
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 80 positions in its portfolio as reported in the June 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Turning Point Therapeutics I | 6.7 | $177M | 2.7M | 64.59 | |
Chemocentryx | 5.9 | $155M | 2.7M | 57.54 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 5.9 | $154M | 500k | 308.36 | |
Forma Therapeutics Hldgs SHS | 5.8 | $153M | 3.4M | 45.14 | |
Principia Biopharma | 3.6 | $95M | 1.6M | 59.79 | |
Bridgebio Pharma (BBIO) | 3.2 | $85M | 2.6M | 32.61 | |
Revolution Medicines (RVMD) | 3.2 | $83M | 2.6M | 31.38 | |
Ishares Tr Russell 2000 Etf Put Option (IWM) | 2.7 | $72M | 500k | 143.18 | |
Y Mabs Therapeutics (YMAB) | 2.6 | $68M | 1.6M | 43.20 | |
Avidity Biosciences Ord (RNA) | 2.6 | $68M | 2.5M | 26.96 | |
Apellis Pharmaceuticals (APLS) | 2.6 | $68M | 2.1M | 32.66 | |
Viela Bio | 2.5 | $66M | 1.5M | 43.32 | |
Reata Pharmaceuticals Cl A | 2.4 | $62M | 400k | 156.02 | |
Myokardia | 2.2 | $58M | 600k | 96.62 | |
Acceleron Pharma | 2.2 | $57M | 600k | 95.27 | |
Mirati Therapeutics | 2.2 | $57M | 500k | 114.17 | |
Spdr Ser Tr S&p Biotech Put Option (XBI) | 2.1 | $56M | 500k | 111.95 | |
Myovant Sciences | 2.0 | $52M | 2.5M | 20.62 | |
Eidos Therapeutics | 1.9 | $50M | 1.1M | 47.67 | |
Biohaven Pharmaceutical Holding | 1.7 | $44M | 600k | 73.11 | |
Agenus Com New | 1.6 | $43M | 11M | 3.93 | |
Omeros Corporation (OMER) | 1.6 | $41M | 2.8M | 14.72 | |
Sorrento Therapeutics Com New (SRNE) | 1.6 | $41M | 6.5M | 6.28 | |
Stoke Therapeutics (STOK) | 1.5 | $41M | 1.7M | 23.83 | |
Arcturus Therapeutics Hldg I (ARCT) | 1.4 | $37M | 800k | 46.74 | |
Rocket Pharmaceuticals (RCKT) | 1.2 | $31M | 1.5M | 20.93 | |
Crispr Therapeutics Namen Akt (CRSP) | 1.1 | $29M | 400k | 73.49 | |
Axsome Therapeutics (AXSM) | 1.1 | $29M | 350k | 82.28 | |
Blueprint Medicines (BPMC) | 1.0 | $27M | 350k | 78.00 | |
Ascendis Pharma A S Sponsored Adr (ASND) | 1.0 | $26M | 175k | 147.90 | |
Axonics Modulation Technolog (AXNX) | 1.0 | $25M | 720k | 35.11 | |
Twist Bioscience Corp (TWST) | 1.0 | $25M | 553k | 45.30 | |
Igm Biosciences (IGMS) | 0.9 | $25M | 340k | 73.00 | |
Tricida | 0.9 | $24M | 872k | 27.48 | |
Cabaletta Bio (CABA) | 0.9 | $24M | 2.1M | 11.14 | |
Satsuma Pharmaceuticals Ord | 0.9 | $23M | 799k | 28.76 | |
Beam Therapeutics (BEAM) | 0.8 | $22M | 796k | 27.67 | |
Quotient SHS | 0.8 | $22M | 2.9M | 7.40 | |
Zai Lab Adr (ZLAB) | 0.8 | $21M | 250k | 82.13 | |
Uniqure Nv SHS (QURE) | 0.8 | $20M | 444k | 45.06 | |
Zymeworks | 0.8 | $20M | 550k | 36.07 | |
Anaptysbio Inc Common (ANAB) | 0.8 | $20M | 886k | 22.34 | |
Galapagos Nv Spon Adr (GLPG) | 0.7 | $20M | 99k | 196.66 | |
Deciphera Pharmaceuticals | 0.7 | $19M | 319k | 59.72 | |
Pliant Therapeutics (PLRX) | 0.7 | $19M | 611k | 30.77 | |
Sarepta Therapeutics (SRPT) | 0.7 | $18M | 110k | 160.34 | |
Argenx Se Sponsored Adr (ARGX) | 0.6 | $16M | 70k | 225.23 | |
Nextcure (NXTC) | 0.6 | $15M | 694k | 21.44 | |
Akero Therapeutics (AKRO) | 0.6 | $15M | 593k | 24.92 | |
Allakos (ALLK) | 0.5 | $14M | 198k | 71.86 | |
Inspire Med Sys (INSP) | 0.5 | $13M | 148k | 87.02 | |
Insmed Com Par $.01 (INSM) | 0.5 | $12M | 450k | 27.54 | |
Biontech Se Sponsored Ads (BNTX) | 0.4 | $12M | 175k | 66.74 | |
Kura Oncology (KURA) | 0.4 | $11M | 700k | 16.30 | |
Repare Therapeutics Ord (RPTX) | 0.4 | $11M | 353k | 31.02 | |
Harpoon Therapeutics | 0.4 | $11M | 645k | 16.60 | |
Akouos | 0.4 | $11M | 500k | 21.34 | |
Merus N V (MRUS) | 0.4 | $9.7M | 600k | 16.09 | |
Kadmon Hldgs | 0.4 | $9.2M | 1.8M | 5.12 | |
Homology Medicines | 0.3 | $8.4M | 550k | 15.19 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $7.7M | 480k | 16.03 | |
Aveo Pharmaceuticals Com New | 0.3 | $7.0M | 1.4M | 5.15 | |
Atreca Cl A Com (BCEL) | 0.3 | $6.8M | 321k | 21.28 | |
Burning Rock Biotech Sponsored Ads | 0.3 | $6.8M | 250k | 27.01 | |
Kezar Life Sciences (KZR) | 0.3 | $6.7M | 1.3M | 5.18 | |
Eiger Biopharmaceuticals | 0.3 | $6.7M | 700k | 9.60 | |
Genetron Hldgs Ads | 0.2 | $6.0M | 500k | 12.07 | |
Avrobio Ord (AVRO) | 0.2 | $5.5M | 318k | 17.45 | |
Arena Pharmaceuticals Com New | 0.2 | $4.7M | 75k | 62.95 | |
Arya Sciences Acquisition Unit 06/09/2027 | 0.2 | $4.6M | 400k | 11.60 | |
Gossamer Bio (GOSS) | 0.2 | $4.5M | 349k | 13.00 | |
Amarin Corp Spons Adr New (AMRN) | 0.2 | $4.2M | 600k | 6.92 | |
Nektar Therapeutics (NKTR) | 0.1 | $2.9M | 125k | 23.16 | |
Precision Biosciences Ord | 0.1 | $2.9M | 347k | 8.33 | |
Theravance Biopharma (TBPH) | 0.1 | $2.1M | 100k | 20.99 | |
Minerva Neurosciences | 0.1 | $1.8M | 512k | 3.61 | |
X4 Pharmaceuticals (XFOR) | 0.1 | $1.8M | 329k | 5.34 | |
Fate Therapeutics (FATE) | 0.1 | $1.7M | 50k | 34.32 | |
Orchard Therapeutics Ads | 0.1 | $1.5M | 257k | 6.00 | |
Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $117k | 417k | 0.28 |